Medtronic plc is a global leader in developing, manufacturing, and selling device-based medical therapies that cater to the diverse needs of healthcare systems, physicians, clinicians, and patients worldwide. With a rich history dating back to 1949, the company has established itself as a pioneer in the medical technology industry.
The company's Cardiovascular Portfolio segment offers a comprehensive range of products, including implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices. These devices are designed to treat various heart conditions, such as arrhythmias and heart failure. Additionally, the segment provides cardiac ablation products, insertable cardiac monitor systems, and TYRX products, which are used to treat conditions like atrial fibrillation and ventricular tachycardia. The segment also offers aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, which are used to treat conditions like aortic stenosis and pulmonary valve disease.
Medtronic's Neuroscience Portfolio segment focuses on developing medical devices and implants that cater to the needs of spinal surgeons, neurosurgeons, neurologists, pain management specialists, and other medical professionals. The segment offers spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, including the Accurian nerve ablation system. These products are designed to treat conditions like chronic pain, Parkinson's disease, and epilepsy. The segment also offers energy surgical instruments, which are used in various surgical procedures.
The Medical Surgical Portfolio segment provides a wide range of products, including surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, and AI-powered surgical video and analytics platforms. The segment also offers robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, and gastrointestinal and hepatologic diagnostics and therapies. Additionally, the segment provides patient monitoring and airway management products, which are used to ensure patient safety during surgical procedures.
Medtronic's Diabetes Operating Unit segment focuses on developing innovative products for people with diabetes. The segment offers insulin pumps and consumables, continuous glucose monitoring systems, and the InPen smart insulin pen system. These products are designed to help people with diabetes manage their condition more effectively and improve their quality of life.
Headquartered in Galway, Ireland, Medtronic plc is a publicly traded company listed on the XETRA stock exchange under the ticker symbol 2M6. The company's common stock is classified under the Health Care Equipment sub-industry, and its ISIN is IE00BTN1Y115. For more information, please visit the company's website at https://www.medtronic.com.